Top-Down Induced Crystallization Orientation toward Highly Efficient p-i-n Perovskite Solar Cells

© 2024 Wiley‐VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 24 vom: 08. Juni, Seite e2313524
1. Verfasser: Jiang, Xiaofen (VerfasserIn)
Weitere Verfasser: Liu, Baoze, Wu, Xin, Zhang, Shoufeng, Zhang, Dong, Wang, Xue, Gao, Shuang, Huang, Zongming, Wang, Haolin, Li, Bo, Xiao, Zhengguo, Chen, Tao, Jen, Alex K-Y, Xiao, Shuang, Yang, Shangfeng, Zhu, Zonglong
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article crystallization orientation homogeneity p‐i‐n perovskite solar cells top‐down engineering
Beschreibung
Zusammenfassung:© 2024 Wiley‐VCH GmbH.
Crystallization orientation plays a crucial role in determining the performance and stability of perovskite solar cells (PVSCs), whereas effective strategies for realizing oriented perovskite crystallization is still lacking. Herein, a facile and efficient top-down strategy is reported to manipulate the crystallization orientation via treating perovskite wet film with propylamine chloride (PACl) before annealing. The PA+ ions tend to be adsorbed on the (001) facet of the perovskite surface, resulting in the reduced cleavage energy to induce (001) orientation-dominated growth of perovskite film and then reduce the temperature of phase transition, meanwhile, the penetrating Cl ions further regulate the crystallization process. As-prepared (001)-dominant perovskite films exhibit the ameliorative film homogeneity in terms of vertical and horizontal scale, leading to alleviated lattice mismatch and lowered defect density. The resultant PVSC devices deliver a champion power conversion efficiency (PCE) of 25.07% with enhanced stability, and the unencapsulated PVSC device maintains 95% of its initial PCE after 1000 h of operation at the maximum power point under simulated AM 1.5G illumination
Beschreibung:Date Revised 13.06.2024
published: Print-Electronic
Citation Status PubMed-not-MEDLINE
ISSN:1521-4095
DOI:10.1002/adma.202313524